Article Versions Notes

Gečys D, Akramas L, Preikšaitis A, Balnytė I, Vaitkevičius A, Šimienė J, Stakišaitis D. Comparison of the Effect of the Combination of Sodium Valproate and Sodium Dichloroacetate on the Expression of SLC12A2, SLC12A5, CDH1, CDH2, EZH2, and GFAP in Primary Female Glioblastoma Cells with That of Temozolomide. Pharmaceutics. 2025; 17(9):1161. https://doi.org/10.3390/pharmaceutics17091161

Gečys, Dovydas, Laimis Akramas, Aidanas Preikšaitis, Ingrida Balnytė, Arūnas Vaitkevičius, Julija Šimienė, and Donatas Stakišaitis. 2025. "Comparison of the Effect of the Combination of Sodium Valproate and Sodium Dichloroacetate on the Expression of SLC12A2, SLC12A5, CDH1, CDH2, EZH2, and GFAP in Primary Female Glioblastoma Cells with That of Temozolomide" Pharmaceutics 17, no. 9: 1161. https://doi.org/10.3390/pharmaceutics17091161

Gečys, D., Akramas, L., Preikšaitis, A., Balnytė, I., Vaitkevičius, A., Šimienė, J., & Stakišaitis, D. (2025). Comparison of the Effect of the Combination of Sodium Valproate and Sodium Dichloroacetate on the Expression of SLC12A2, SLC12A5, CDH1, CDH2, EZH2, and GFAP in Primary Female Glioblastoma Cells with That of Temozolomide. Pharmaceutics, 17(9), 1161. https://doi.org/10.3390/pharmaceutics17091161